59
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension

, , , , , , , , , & show all
Pages 1573-1580 | Published online: 05 May 2016

References

  • ChobanianAVBakrisGLBlackHRSeventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressureHypertension20034261206125214656957
  • ManciaGDe BackerGDominiczakA2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20072561105118717563527
  • KawaiTOhishiMKamideKThe impact of visit-to-visit variability in blood pressure on renal functionHypertens Res201135223924322011685
  • LeeHTLimY-HKimBKThe relationship between ambulatory arterial stiffness index and blood pressure variability in hypertensive patientsKorean Circ J201141523524021731563
  • MasugataHSendaSMuraoKVisit-to-visit variability in blood pressure over a 1-year period is a marker of left ventricular diastolic dysfunction in treated hypertensive patientsHypertens Res201134784685021562506
  • MuntnerPShimboDTonelliMReynoldsKArnettDKOparilSThe relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population findings from NHANES III, 1988 to 1994Hypertension201157216016621200000
  • RothwellPMHowardSCDolanEPrognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertensionLancet2010375971889590520226988
  • Suchy-DiceyAMWallaceERElkindMSBlood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health studyAm J Hypertens201326101210121723744496
  • ConwayJBoonNDaviesCJonesJVSleightPNeural and humoral mechanisms involved in blood pressure variabilityJ Hypertens1984222032086398335
  • ManciaGParatiGPomidossiGCasadeiRDi RienzoMZanchettiAArterial baroreflexes and blood pressure and heart rate variabilities in humansHypertension1986821471533080371
  • OkadaHFukuiMTanakaMVisit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetesAtherosclerosis2012220115515922100253
  • SegaRCesanaGBombelliMSeasonal variations in home and ambulatory blood pressure in the PAMELA populationJ Hypertens19981611158515929856358
  • MatsuiYIshikawaJEguchiKShibasakiSShimadaKKarioKMaximum value of home blood pressure a novel indicator of target organ damage in hypertensionHypertension20115761087109321536993
  • UshigomeEFukuiMHamaguchiMThe coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitusHypertens Res201134121271127521814212
  • KikuyaMOhkuboTMetokiHDay-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis the Ohasama studyHypertension20085261045105018981332
  • RothwellPMLimitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertensionLancet2010375971893894820226991
  • RothwellPHowardSDolanEASCOT-BPLA and MRC Trial InvestigatorsEffects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of strokeLancet Neurol20109546948020227347
  • FukuiMUshigomeETanakaMHome blood pressure variability on one occasion is a novel factor associated with arterial stiffness in patients with type 2 diabetesHypertens Res201236321922523096230
  • SchutteRThijsLLiuY-PWithin-subject blood pressure level – not variability – predicts fatal and nonfatal outcomes in a general populationHypertension20126051138114723071126
  • MasudaSTamuraKWakuiHEffects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathyHypertens Res2009321195095519713965
  • ParatiGDolanELeyLSchumacherHImpact of antihypertensive combination and monotreatments on blood pressure variability: assessment by old and new indices. Data from a large ambulatory blood pressure monitoring databaseJ Hypertens20143261326133324759124
  • ShigenagaA-ITamuraKDejimaTEffects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysisNephron Clin Pract20091121c31c4019342867
  • ParkJBSungK-CKangSMChoEJSafety and efficacy of fimasar-tan in patients with arterial hypertension (Safe-KanArb Study)Am J Cardiovasc Drugs2013131475623344912
  • KimCKimMYKangDRKimJYParkJBK-MetS study investigatorsThe efficacy of fimasartan for cardiovascular events and metabolic syndrome (K-MetS Study): Rationale, design and participant characteristicsPulse (Basel)201413–417718526587436
  • AsmarRKhabouthJTopouchianJEl FeghaliRMattarJValidation of three automatic devices for self-measurement of blood pressure according to the International Protocol: The Omron M3 Intellisense (HEM-7051-E), the Omron M2 Compact (HEM 7102-E), and the Omron R3-I Plus (HEM 6022-E)Blood Pres Monit20101514954
  • CicconettiPCacciafestaMMiglioriMInfluence of sex and age on blood pressure variabilityArch Gerontol Geriatr200030322523610867166
  • ParatiGOchoaJEBiloGBlood pressure variability, cardiovascular risk, and risk for renal disease progressionCurr Hypertens Rep201214542143122903810
  • JohanssonJKNiiranenTJPuukkaPJJulaAMPrognostic value of the variability in home-measured blood pressure and heart rate the Finn-Home StudyHypertension201259221221822215704
  • IchiharaAKaneshiroYTakemitsuTSakodaMEffects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patientsJ Hum Hypertens2006201078779416810279
  • ZhangYAgnolettiDSafarMEBlacherJEffect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) StudyHypertension201158215516021747047
  • NissenSETuzcuEMLibbyPEffect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trialJAMA2004292182217222515536108
  • YoshidaHAkasakaHSaitohSShimamotoKMiuraTComparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapyHypertens Res201337322523124108237
  • PringleEPhillipsCThijsLSystolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive populationJ Hypertens200321122251225714654744